Regarding the pathophysiology and management of acute infectious diarrhea in children, all of the following statements are correct EXCEPT:

Explanation

## Pathophysiology and Evidence-Based Management of Acute Infectious Diarrhea ### Rotavirus Mechanism of Secretory Diarrhea **Key Point:** Rotavirus produces a non-structural protein (NSP4) that acts as an enterotoxin, triggering increased intracellular calcium and cAMP in intestinal epithelial cells, leading to chloride secretion and osmotic diarrhea. This is a well-established mechanism. **High-Yield:** Rotavirus diarrhea is **secretory in nature**, not primarily inflammatory, which is why ORT is highly effective. ### Zinc Supplementation: Evidence-Based Recommendation **Key Point:** WHO and UNICEF recommend zinc supplementation (10–14 mg/day for 10–14 days) for all children with acute diarrhea, regardless of etiology. | Benefit | Evidence | |---|---| | **Reduces duration** | Shortens diarrhea by ~25% | | **Reduces severity** | Decreases stool output | | **Prevents recurrent infections** | Reduces subsequent diarrhea and respiratory infections for 2–3 months | | **Mechanism** | Restores mucosal immunity and epithelial barrier function | ### Antimotility Agents: Contraindication **Warning:** Antimotility agents (loperamide, diphenoxylate) are **contraindicated** in acute diarrhea because: - Increase risk of toxic megacolon (especially in inflammatory diarrhea) - Prolong bacterial shedding and increase invasive complications - May worsen outcomes in infections like Shigella, Salmonella, and Campylobacter **Clinical Pearl:** This is a high-yield exam trap—students often confuse antimotility use in chronic diarrhea (IBS) with acute infectious diarrhea. ### Probiotics: LIMITED Evidence, NOT Strongly Recommended **High-Yield:** This is the **incorrect statement**. Current evidence on probiotics in acute diarrhea is **weak and inconsistent**: | Finding | Status | |---|---| | **Lactobacillus GG** | Modest reduction in duration (1–2 days) in some RCTs; not universally effective | | **Saccharomyces boulardii** | Some evidence for prevention; limited data for treatment | | **WHO/UNICEF recommendation** | **Not routinely recommended** as adjunctive therapy; insufficient evidence | | **Current guideline stance** | May be considered in specific settings (e.g., antibiotic-associated diarrhea) but NOT standard of care | **Key Point:** Probiotics are **not strongly recommended** in acute infectious diarrhea. The evidence base is insufficient to support routine use, and they are not a substitute for ORT, zinc, and continued feeding. ### Summary: Evidence-Based Management Algorithm ```mermaid flowchart TD A[Acute Diarrhea in Child]:::outcome --> B[Assess Dehydration]:::decision B -->|Mild/Moderate| C[ORS 50-75 mL/kg/4h]:::action B -->|Severe/Shock| D[IV Fluids 20 mL/kg bolus]:::action C --> E[Add Zinc 10-14 mg/day × 10-14 days]:::action D --> E E --> F[Continue Feeding + Breastfeeding]:::action F --> G[Avoid Antimotility Agents]:::urgent F --> H[Probiotics: NOT Routine]:::outcome ``` [cite:Park 26e Ch 8; WHO/UNICEF Diarrhea Management Guidelines 2005]